Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study
Philipp Heumann, Juan C. Rosas, Miguel E. Aguado-Barrera, David Azria, Axel Benner, Erik Briers, Renée Bultijnck, Ananya Choudhury, Antonio Gómez-Caamaño, Rudolf Kaaks, Maarten Lambrecht, Tiziana Rancati, Barry S. Rosenstein, Dirk De Ruysscher, Martina E. Schmidt, Susanne Singer, Elena Sperk, Hilary Stobart, Ana Vega, Liv Veldeman, Tim Ward, Adam Webb, Catharine M. West, Jenny Chang-Claude, Christopher J. Talbot, Tim Rattay, Petra Seibold, Piet Ost, Yolande Lievens, Pieter Deseyne, Fréderic Dupr British Journal of Cancer
· Springer Nature
· 2026-11-04
· DOI: 10.1038/s41416-026-03644-2
Abstract
British Journal of Cancer, Published online: 04 November 2026; doi:10.1038/s41416-026-03644-2 Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study
Philipp Heumann, Juan C. Rosas, Miguel E. Aguado-Barrera, David Azria, Axel Benner, Erik Briers et al. Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study. // British Journal of Cancer. – 2026. – DOI: 10.1038/s41416-026-03644-2. – URL: https://www.nature.com/articles/s41416-026-03644-2
Philipp Heumann, Juan C. Rosas, Miguel E. Aguado-Barrera, David Azria, Axel Benner, Erik Briers, Renée Bultijnck, Ananya Choudhury, Antonio Gómez-Caamaño, Rudolf Kaaks, Maarten Lambrecht, Tiziana Rancati, Barry S. Rosenstein, Dirk De Ruysscher, Martina E. Schmidt, Susanne Singer, Elena Sperk, Hilary Stobart, Ana Vega, Liv Veldeman, Tim Ward, Adam Webb, Catharine M. West, Jenny Chang-Claude, Christopher J. Talbot, Tim Rattay, Petra Seibold, Piet Ost, Yolande Lievens, Pieter Deseyne, & Fréderic Dupr (2026). Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03644-2
Philipp Heumann, et al. “Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study.” British Journal of Cancer, 2026. doi:10.1038/s41416-026-03644-2.
@article{Heumann2026,
title = {Long-term fatigue based on the EORTC QLQ-C30 up to five years after radiotherapy and its trajectories in men diagnosed with non-metastatic prostate cancer in the international REQUITE study},
author = {Heumann, Philipp and Rosas, Juan C. and Aguado-Barrera, Miguel E. and Azria, David and Benner, Axel and Briers, Erik and Bultijnck, Renée and Choudhury, Ananya and Gómez-Caamaño, Antonio and Kaaks, Rudolf and Lambrecht, Maarten and Rancati, Tiziana and Rosenstein, Barry S. and Ruysscher, Dirk De and Schmidt, Martina E. and Singer, Susanne and Sperk, Elena and Stobart, Hilary and Vega, Ana and Veldeman, Liv and Ward, Tim and Webb, Adam and West, Catharine M. and Chang-Claude, Jenny and Talbot, Christopher J. and Rattay, Tim and Seibold, Petra and Ost, Piet and Lievens, Yolande and Deseyne, Pieter and Dupr, Fréderic},
journal = {British Journal of Cancer},
year = {2026},
doi = {10.1038/s41416-026-03644-2},
url = {https://www.nature.com/articles/s41416-026-03644-2}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment